Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,496,573 papers from all fields of science
Search
Sign In
Create Free Account
rapacuronium
Known as:
rapacuronium [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Neuromuscular Nondepolarizing Agents
Vecuronium Bromide
Narrower (1)
Org 9487
Rapacuronium bromide
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Rapacuronium Augments Acetylcholine-induced Bronchoconstriction via Positive Allosteric Interactions at the M3 Muscarinic Receptor
E. Jooste
,
Amit K. Sharma
,
Yi Zhang
,
C. Emala
Anesthesiology
2005
Corpus ID: 4537416
Background:Neuromuscular blocking agents’ detrimental airway effects may occur as a result of interactions with muscarinic…
Expand
Highly Cited
2003
Highly Cited
2003
A Mechanism for Rapacuronium-induced Bronchospasm: M2 Muscarinic Receptor Antagonism
E. Jooste
,
Farrah Klafter
,
C. Hirshman
,
C. Emala
Anesthesiology
2003
Corpus ID: 13063601
Background A safe and effective ultra-short-acting nondepolarizing neuromuscular blocking agent is required to block nicotinic…
Expand
Review
2002
Review
2002
Rapacuronium and the Risk of Bronchospasm in Pediatric Patients
Donna M Rajchert
,
C. Pasquariello
,
M. Watcha
,
M. Schreiner
Anesthesia and Analgesia
2002
Corpus ID: 22517438
We conducted this study to determine the risk factors for the development of bronchospasm after the administration of…
Expand
2001
2001
Bronchospasm after rapacuronium in infants and children.
G. Meakin
,
Erik H. Pronske
,
+4 authors
A. Lynn
Anesthesiology
2001
Corpus ID: 32529015
IN December 2000, subscribers to the Paediatric Anaesthesia Conference discussion group were invited to post their experiences…
Expand
2000
2000
Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1.
Manfred Blobner
,
R. Mirakhur
,
+7 authors
H. Sparr
British Journal of Anaesthesia
2000
Corpus ID: 35022188
The purpose of this nine-centre study in 602 patients was to show that the frequency of acceptable intubating conditions after…
Expand
2000
2000
Reversal of Rapacuronium Block During Propofol Versus Sevoflurane Anesthesia
Tian J. Zhou
,
Jun Tang
,
+5 authors
T. Webb
Anesthesia and Analgesia
2000
Corpus ID: 41342435
We studied the antagonism of rapacuronium with edrophonium-atropine during propofol- or sevoflurane- based anesthesia in 60…
Expand
2000
2000
A Dose-ranging Study of Rapacuronium in Pediatric Patients
G. Meakin
,
O. Meretoja
,
+5 authors
A. McCluskey
Anesthesiology
2000
Corpus ID: 16370545
Background: The aim of this study was to determine the dose or doses of the new rapid-onset, short-acting, neuromuscular blocking…
Expand
1999
1999
The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia.
J. Levy
,
M. Pitts
,
Apostolos Thanopoulos
,
F. Szlam
,
R. Bastian
,
John Kim
Anesthesia and Analgesia
1999
Corpus ID: 45808432
UNLABELLED Neuromuscular blocking drugs may have variable effects on heart rate (HR) and blood pressure. Rapacuronium is a rapid…
Expand
1999
1999
Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488).
S. Schiere
,
J. Proost
,
M. Schuringa
,
J. Wierda
Anesthesia and Analgesia
1999
Corpus ID: 23311220
UNLABELLED Rapacuronium (Org 9487) is a rapid-onset and short- to intermediate-acting muscle relaxant. Its 3-desacetyl metabolite…
Expand
1999
1999
Pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
P. Duvaldestin
,
V. Slavov
,
Y. Rebufat
Anesthesiology
1999
Corpus ID: 13704198
BACKGROUND Delayed elimination kinetics of steroidal neuromuscular blocking agents have been observed in patients with cirrhosis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE